EQS-AFR: Dermapharm Holding SE: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements
Summary by AI BETAClose X
Dermapharm Holding SE has announced that its first-quarter financial report will be disclosed on May 13, 2026, in both German and English. This preliminary announcement indicates the upcoming release of key financial data that will provide investors with an update on the company's performance during the initial period of the year.
|
EQS Preliminary announcement financial reports: Dermapharm Holding SE
/ Preliminary announcement on the disclosure of financial statements
Dermapharm Holding SE hereby announces that the following financial reports shall be disclosed:
Report Type: Quarterly financial report within the 1st half-year (Q1) Language: German Date of disclosure: May 13, 2026 Address: https://ir.dermapharm.de/de/investor-relations/finanzberichte-praesentationen/ Language: English Date of disclosure: May 13, 2026 Address: https://ir.dermapharm.de/en/investor-relations/financial-reports-presentations/
04.05.2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Dermapharm Holding SE |
| Lil-Dagover-Ring 7 | |
| 82031 Grünwald | |
| Germany | |
| Internet: | ir.dermapharm.de |
| End of News | EQS News Service |
|
|
2320432 04.05.2026 CET/CEST
Latest directors dealings
- 4 hours ago XP Factory
- 4 hours ago Breedon Group
- 5 hours ago SIG
- 5 hours ago React Group
- 7 hours ago AJ Bell